Patent Assignment
Reel/Frame 024116/0375
Corrective Assignment to Change the Serial Number from 10/893863 to 11/949529 Assignment Previously Recorded on Reel 023951/ Frame 0183.
Recorded: 2010-03-22
Pages: 8
Assignors
CHEN, GENHUI
Executed: 2004-11-10
WEBSTER, JOHN M.
Executed: 2004-11-10
LI, JIANXIONG
Executed: 2004-11-10
HU, KAJI
Executed: 2004-11-10
ZHU, JIANG
Executed: 2004-11-02
LIU, WEI
Executed: 2004-11-10
Assignee
WELICHEM BIOTECH INC.
4475 WAYBURNE DRIVE, SUITE 316, BURNABY, BRITISH COLUMBIA, V5G 3L1, CANADA
Covered Property
(1)
Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 20, 2012
From: WELICHEM BIOTECH INC.
To: GLAXO GROUP LIMITED
Reel/Frame 028811/0458 →
Security Interest
Aug 24, 2018
From: DERMAVANT SCIENCES GMBH
To: NOVAQUEST CO-INVESTMENT FUND VIII, L.P.
Reel/Frame 046697/0848 →
Assignment of Assignor's Interest
Sep 6, 2018
From: GLAXO GROUP LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047028/0116 →
Intellectual Property Security Agreement
May 24, 2019
From: DERMAVANT SCIENCES GMBH
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 049285/0377 →
Release of Security Interest
Sep 3, 2024
From: HERCULES CAPITAL, INC., AS AGENT
To: DERMAVANT SCIENCES GMBH
Reel/Frame 068471/0692 →